NCRTP-HepC Directory

Menu Home   About the NCRTP-HepC Mission & Objectives Fellowships & Awards Training Curriculum E-Newsletters Sponsors & Support Directory   Member Services   Contact Us Number of Visitors since May 31, 2007: 274358

Gary Levy mentor Send message Address   University Health Network Toronto General Hospital 585 University Ave, NCSB-11-1236 Toronto ON M5G 2N2   Tel   416-340-5166 Fax   416-340-3378 Email   glfgl2@attglobal.net   Biography   Dr. Levy graduated from medical school at the University of Toronto in 1973. He completed his training in hepatology at the University of Toronto in 1978 and undertook postdoctoral training in immunology at the Scripps Clinic and Research Foundation from 1978-81. Dr. Levy founded and became the Medical Director of the Liver Transplant Unit at the Toronto General Hospital and University of Toronto in 1987. In 1991, he organized and co-founded their Multi Organ Transplant Unit. He is currently a Professor in the Departments of Medicine and Surgery at the University of Toronto and Director of the Multi Organ Transplant Program at the University Health Network and University of Toronto. He has organized and now heads a research group of 11 principle investigators which is focused on studying cellular and molecular mechanisms of inflammation. His research, funded by the Canadian Institutes for Health Research and the National Institutes of Health has focused on immune-mediated mechanisms of organ injury due to viruses, alloantigens, and xenoantigens. He has published over 250 original articles, books and book chapters. He currently holds the Novartis Chair in Transplantation at the University of Toronto. Dr. Levy is also the PI of the CIHR research training program in Regenerative Medicine. He has received a number of honors including election to the American Society for Clinical Investigation, the Goldie Prize in Medicine, the Canadian Association of Gastroenterology Visiting Research Professorship and the University of Toronto, Department of Medicine Research Award for outstanding contributions to research. He is a member of the following editorial boards: Transplantation Science, Transplantation, Liver Transplantation and Surgery and Current Opinion in Organ Transplantation and is a member of an advisory board for Health Canada in transplantation and xenotransplantation. He served as the Chief Scientific Officer of Transplantation Technologies Inc., from 1997 to 2002 and is part of a consortium of scientists to examine the feasibility of clinical xenotransplantation. He was recently awarded the Canadian Liver Foundation Commemorative Medal for the Queen's Jubilee for his contribution to liver disease in Canada.   Testimony     Disciplines   Hepatology; Immunology; [top]